OPEN APP
Home >Industry >Manufacturing >World’s drug bill to rise to $1.4 trillion in 2020: Report
The US will spend the most on drugs, with 41% of the global bill. China will spend $150 billion to $180 billion in 2020, representing a 6% to 9% compound annual growth rate. The global growth rate is 4% to 7%. Photo: Bloomberg
The US will spend the most on drugs, with 41% of the global bill. China will spend $150 billion to $180 billion in 2020, representing a 6% to 9% compound annual growth rate. The global growth rate is 4% to 7%. Photo: Bloomberg

World’s drug bill to rise to $1.4 trillion in 2020: Report

According to a report so-called specialty therapies will dominate spending, with oncology treatments totalling $110 billion, followed by autoimmune drugs

San Francisco: The world’s annual pharmaceutical bill will grow by about a third to $1.4 trillion in 2020 as brand-name drugs for cancers and rare diseases come to market, according to researchers at the IMS Institute for Healthcare Informatics.

Among the report’s top findings are:

- So-called specialty therapies will dominate spending, with oncology treatments totalling $110 billion, followed by autoimmune drugs. Treatments for viral hepatitis, including Gilead Science Inc.’s hepatitis C drugs Sovaldi and Harvoni along with AbbVie Inc.’s Viekira Pak, will make up $48 billion.

- The US will spend the most on drugs, with 41% of the global bill. China will spend $150 billion to $180 billion in 2020, representing a 6% to 9% compound annual growth rate. The global growth rate is 4% to 7%.

- IMS estimates 225 new treatments will be introduced in the next five years. Of these, drugs for rare diseases and cancers will dominate. Bloomberg

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Close
×
Edit Profile
My Reads Redeem a Gift Card Logout